Key Opinion Leader Development. Tony Moses President, A-Z Eye Consultants National Manager, eyecheck LLC

Similar documents
Defining Strategic Metrics to Demonstrate Impact

POSITION DESCRIPTIONS

Keywords: fi eld-medical, medical science liaisons, metrics, return on investment, consensus

Multi-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes

Aligning internal teams to secure buy-in from external stakeholders: a critical part of launch strategy

BOARD OF DIRECTORS PAPER COVER SHEET. Meeting Date: 27 January 2010

Breaking the Silo Mentality Working With Opinion Leaders

COMMUNITY HEALTH WORKERS Multi-disciplinary Effort to Promote CHW Sustainability in a Bi-state, Regional Community

EVALUATING PERFORMANCE: Evolving Approaches To Evaluating Performance Measurement Programs

DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE

From discussion to implementation: How to negotiate and implement a risk-sharing agreement

Career opportunity: Executive Vice President and General Manager, Worldwide - Wolters Kluwer Finance, Risk and Regulatory Reporting (FRR) - London

Current Trends in the Biomedical Industry Series. Session 10 Marketing Practices for Product Launch October 31, 2007

ASSISTANCE AND ASSESSMENT:

Reputation and the Board. Guidance for PR Consultants and Board Directors

BEST PRACTICES IN BEST PRACTICES IN STUDY FEASIBILITY

MARKET RESEARCH AT ADELPHI SEPTEMBER 2016

Trade in your lab coat for a career in healthcare advertising

MARKET ACCESS & PUBLIC AFFAIRS MANAGER BELUX

Ontario Hospital Association. Strategic Plan

Capabilities and Competencies in the New Medical Affairs: A Roadmap To Success. Charlotte Kremer Charlotte Raabe - Hielscher Mary Alice Dwyer

Hierarchy of Marketing Metrics: Measuring Success Like a CFO

Electronic Health Records in a System of Care Setting: Lessons Learned from the Field

Digging Deeper: Focus on Best Practices Medical Affairs Compliance

The precise methodology of the ranking and the results of the process are fully disclosed.

CSR / Sustainability Governance and Management Assessment By Coro Strandberg President, Strandberg Consulting

Key Activities. Ofer Reizes, Ph.D. Skills Development Director

Executive Search. Chief Standards Officer

Improving corporate behavior in a way that positively impacts the world. Anti-Bribery Management Systems ETHISPHERE ISO CERTIFICATION

Pharmamarketing - strategic challenges

The One Metric for Cultivating Patient Loyalty and Spurring Positive Word of Mouth

Case for Product Quality Outcomes Analytics 26-October-2016

Helping unlock growth opportunities worldwide

Managing Third-Party Relationships

Conversations Everywhere. Are You Listening?

Webinar Series Physician Relations. Referral Development. Advancing the Physician Relations Program Structure

Program-Specific Reports: Past, Present and Future. Where do we go from here?

Metric of the Month. Net Promoter Score. By Jeff Rumburg Managing Partner at:

VFA Peer Benchmarking

confidence. High-quality pharmaceutical market research that enables confident tactical and strategic business decisions

How it works: Questions from the OCAT 2.0

Sustainability Toolkit and Learning Collaborative PREPARED FOR BMS FOUNDATION GRANTEE SUMMIT APRIL 11, 2018

HOW TO IDENTIFY & PRIORITIZE TRIAL STAKEHOLDERS

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

Biologics Account Manager. Account Manager/Key Account Manager. Bio-Dermatology. UK Field Based. Regional Business Manager

WHITE PAPER. Engaging the Evolving Stakeholder Network: A New Approach for Medical Affairs

Change Healthcare Performance Analytics. Identify Opportunities for Financial, Clinical, and Operational Improvement

STATE OF THE ASIA-PACIFIC PHARMACEUTICAL INDUSTRY 2013: EXECUTIVE SUMMARY

FACTORS SUPPORTING A SUSTAINABLE EUROPEAN BIOSIMILAR MEDICINES MARKET

AUDIT COMMITTEE ANNUAL REPORT TO TRUST BOARD 2012/13

Supporting and applying research in the NHS. 1. Overview

Customer Satisfaction Survey Report Guide

Assuring Integrity while Facilitating Innovation in Medical Research

Indiana Youth Group Strategic Plan

BUILDING BLOCKS FOR AN EFFECTIVE INTERNAL AUDIT FUNCTION Presentation by:

THE HEALTHCARE SUPPLY CHAIN LEADER OF THE FUTURE

Roles and responsibilities of MSLs in a life sciences organization

Compliance on the Road: Government and Industry Efforts to Monitor Field Force

Evaluation of the Prime Partnership between Accelence and Quintiles. James Brook Senior Director, Head Site Management Western Europe, Quintiles

Wicomico County Health Department Strategic Plan

North Dakota Medicare Rural Hospital Flexibility Program BALANCED SCORECARD FOR SMALL RURAL HOSPITALS

Optimizing the Impact of the Medical Affairs Function

Finding the Balance between Clinical & Commercial Key Roles. Stewart Geary Chief Medical Officer, Senior Vice President, Eisai, Japan

Diversifying the MSL-KOL Relationships: The Prominent Rise of the Pharmacist KOLs Key Study Findings

Panel Discussion MINI SUMMIT XIII: global fair market value update

Industry Report: The State of QPP Preparedness

Performance Management and Quality Improvement Plan

Planning for Successful Medical Device Reimbursement:

3. Why is California taking the lead in this area? 4. Is this just a California initiative? Aren t ACOs important throughout the country?

CHESAPEAKE BAY MARITIME MUSEUM STRATEGIC PLAN

Hours per week: 37.5 hours per week (office hours are 9:00am 5:30pm Monday to Friday)

Reward next practices

Physician Marketing & Outreach Growing Referring Physician Lifetime Value

University of Pennsylvania Biomedical and Life Sciences Career Fair

Engineers as Entrepreneurs (Class 11.1 April 2, 2013) CSE 3316 Professional Practices Spring 2013 Instructor Bill Carroll, Professor of CSE

Portfolio Marketing. Research and Advisory Service

Developing an Integrated Anti-Fraud, Compliance, and Ethics Program

Global Employee Engagement Survey MAY 2017 GLOBAL ENGAGEMENT SURVEY 2017

37.5 (core office hours are 9:00am 5:30pm Monday to Friday)

Performance Profile. Medical Clinical Director. 1

Corporate Social Responsibility (CSR) Statutory Report Innovating antibodies, improving lives

Physician Relations. Data, Insights & Execution

How to Ensure Departmental Revenue Cycle Accountability and Ownership

A Guide for Assessing Health Research Knowledge Translation (KT) Plans

Business Optimization and Advisory Services

CASE STUDY. Brand awareness through thought leadership and. media visibility

HEDIS Measures NCQA s 20 Years of Experience with Measurement

Value Messages: Developing, Incorporating, and Making Use of a Core Strategic Tool

Global Supplier Diversity & Inclusion Reaching the Gold Standard

From Volume to Value: Using payer insights to increase sales effectiveness

2012 North American Clinical Laboratory Competitive Strategy Leadership Award

Developing Drugs for Rare Diseases: Patient Advocacy s Perspective. Kristina Bowyer Executive Director, Patient Advocacy

Strategic Plan. Uniting to care & cure

Evaluating Payer Opinion versus Behavior for Better Decision Making

CAP Strategic Research: White Paper 9. THE Financial Benefits of Improving Your Brand

Pre-Conference Workshop, September 5, 2017 Location: Murano Ballroom Third Floor of The Palazzo Hotel

Outline for New Board Member Orientation

SAMPLE. North America Trauma Fixation Procedures Outlook to 2020

LEADING THROUGH CHANGE: Leveraging External Partnerships to Implement Clinical Projects Across Mayo Clinic Health System

Care by Design. Fisher & Paykel Healthcare Investor Day Sydney, October 2017

Transcription:

Tony Moses President, A-Z Eye Consultants National Manager, eyecheck LLC

What defines a KOL? What are the most important KOL activities? Why build a KOL Program? How to build a KOL Program? When to begin a KOL Program? Who manages a KOL Program? How to measure a successful KOL Program?

What defines a Key Opinion Leader (KOL)? KOLs are the experts in their field through their experience, seniority, position and reputation Individuals who take an active role in the thinking, discussion and shaping of clinical practice at a local, national and/or global level Individuals whose views influence peers and healthcare organizations KOLs have become entwined with the marketing of medical devices

What are the most important KOL activities? Highest value was placed on the following activities: Supporting Advisory Boards Delivering Scientific Presentations Investigator-Initiated Research KOL Relationship Management Best Practices LLC Strategic Benchmarking Research

Why build a KOL Program? Identification and utilization of KOLs is beneficial in all aspects of an organization Professional Relationships Clinical Trials Clinical Papers Podium Presentations Funding Regulatory/Reimbursement Geographic/Tx Expansion Market Education

How to build a KOL Program? KOL Mapping Strategy Near term and long term assessment of KOL needs KOLs are often segmented in terms of region and expertise Internal teams are required for domestic and international KOL programs Incorporate KOL feedback at during all phases of product lifecycle KOLs will likely change during the product/technology lifecycle Who are the influencers in your environment? MD s Established thought leaders for new product/technology Rising stars to carry on the message through product life Payers Health Economists Patient Advocacy Groups Remuneration at Fair Market Value

When to begin a KOL Program? Ideally, KOL identification and development is done during clinical phase Product Development Process Design Validation / Concept / Feasibility Clinical Market Approval Post Market Preclinical Assistance with clinical design Podium presence AT EVERY POSSIBLE OPPORTUNITY Build long-term collaboration between key company stakeholders and KOLs

Who manages a KOL Program? Head of clinical program or CMO should be in charge of KOL Program Head of sales and/or marketing must also be actively involved Other stakeholders are CEO and head of R&D

How to measure a successful KOL Program? Put metrics in place to review on a regular basis # of interactions with KOL during a specific period KOL response time Time invested in building a new KOL relationship KOLs level of satisfaction with working relationship Other metrics? Continuous review of KOL Program by management team Solicit KOL feedback via annual in-person meetings Seek Peer to Peer feedback to determine strength of KOLs Create KOL survey to obtain potential hidden weaknesses or gems

Final Thoughts A successful KOL Program must have. a defined long-term strategy the full support of the entire organization an internal team dedicated to KOL management a genuinely collaborative approach with chosen thought leaders a system to measure and evaluate KOL interaction shared learning within all departments of the organization clear understanding of legal limits for KOL interaction